1.
Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates
by Tang, Christoph M
Nature, 2009, Vol.458 (7240), p.890-893
2.
Opa proteins and CEACAMs: pathways of immune engagement for pathogenic Neisseria
by Sadarangani, Manish
FEMS microbiology reviews, 2011, Vol.35 (3), p.498-514
3.
Detection of LP2086 on the cell surface of Neisseria meningitidis and its accessibility in the presence of serogroup B capsular polysaccharide
by McNeil, Lisa K
Vaccine, 2009, Vol.27 (25), p.3417-3421
4.
Characterization of size, structure and purity of serogroup X Neisseria meningitidis polysaccharide, and development of an assay for quantification of human antibodies
by Xie, Ouli
Vaccine, 2012, Vol.30 (40), p.5812-5823
5.
Lipid-modified azurin of Neisseria meningitidis is a copper protein localized on the outer membrane surface and not regulated by FNR
by Deeudom, Manu
Antonie van Leeuwenhoek, 2015, Vol.107 (4), p.1107-1116
6.
Efficacy of a capsule conjugate vaccine against inhalational anthrax in rabbits and monkeys
by Chabot, Donald J
Vaccine, 2011, Vol.30 (5), p.846-852
7.
8.
Immunogenicity and some safety features of a VEGF-based cancer therapeutic vaccine in rats, rabbits and non-human primates
by Morera, Yanelys
Vaccine, 2010, Vol.28 (19), p.3453-3461
9.
MATS: Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine
by Medini, Duccio
Vaccine, 2015, Vol.33 (23), p.2629-2636
10.
11.
Structural Bioinformatics of Neisseria meningitidis LD-Carboxypeptidase: Implications for Substrate Binding and Specificity
by Rashid, Yasmeen
Protein Journal, 2011, Vol.30 (8), p.558-565
12.
Incorporation of LpxL1, a detoxified lipopolysaccharide adjuvant, in influenza H5N1 virosomes increases vaccine immunogenicity
by de Vries, J.J.C
Vaccine, 2009, Vol.27 (6), p.947-955
13.
Very small size proteoliposomes derived from Neisseria meningitidis: An effective adjuvant for generation of CTL responses to peptide and protein antigens
by Mesa, Circe
Vaccine, 2006, Vol.24 (14), p.2692-2699
14.
Relative stability of meningococcal serogroup A and X polysaccharides
by Berti, F
Vaccine, 2012, Vol.30 (45), p.6409-6415
15.
16.
17.
Capsule null locus meningococci: Typing of antigens used in an investigational multicomponent meningococcus serogroup B vaccine
by Claus, Heike
Vaccine, 2011, Vol.30 (2), p.155-160
18.
Proteoliposome derived cochleate as novel adjuvant
by Bracho, Gustavo
Vaccine, 2006, Vol.24 Suppl 2, p.S2-30-1
19.
Molecular methods for the detection and characterization of Neisseria meningitidis
by Diggle, Mathew A
Expert review of molecular diagnostics, 2006, Vol.6 (1), p.79-87
20.
A novel intranasal Protollin ™-based measles vaccine induces mucosal and systemic neutralizing antibody responses and cell-mediated immunity in mice
by Chabot, Sophie
Vaccine, 2005, Vol.23 (11), p.1374-1383
